Charles Schwab Investment Management Inc Fulgent Genetics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 294,940 shares of FLGT stock, worth $5.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294,940
Previous 267,313
10.34%
Holding current value
$5.89 Million
Previous $7.73 Million
17.18%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding FLGT
# of Institutions
199Shares Held
14.7MCall Options Held
1.16MPut Options Held
92.9K-
Black Rock Inc. New York, NY3.92MShares$78.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$28.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.35MShares$26.9 Million0.01% of portfolio
-
State Street Corp Boston, MA824KShares$16.5 Million0.0% of portfolio
-
Park West Asset Management LLC Larkspur, CA730KShares$14.6 Million1.15% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $605M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...